Effects of MTor and Insulin Receptor Inhibition in Tamoxifen Resistant Breast Cancer Cells

被引：0
|
作者：
Mietzsch, F. [1 ]
Sinn, H. P. [1 ]
Schirmacher, P. [1 ]
Aulmann, S. [1 ]
机构：
[1] Univ Heidelberg, Inst Pathol, D-6900 Heidelberg, Germany
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S125 / S125
页数：1
相关论文
共 50 条
  • [41] mTOR signaling and tamoxifen response in postmenopausal breast cancer
    Bostner, Josefine
    Karlsson, Elin
    Pandiyan, Muneeswaran Jayachandra
    Fornander, Tommy
    Nordenskjold, Bo
    CLINICAL CANCER RESEARCH, 2012, 18 (10)
  • [42] ESTROGEN-RECEPTOR MUTATIONS IN TAMOXIFEN-RESISTANT BREAST-CANCER
    KARNIK, PS
    KULKARNI, S
    LIU, XP
    BUDD, GT
    BUKOWSKI, RM
    CANCER RESEARCH, 1994, 54 (02) : 349 - 353
  • [43] Effects of vitamin D on tamoxifen resistant breast cancer cell growth
    Chow, Rachel Y.
    Siewit, Christina L.
    Louie, Maggie C.
    FASEB JOURNAL, 2009, 23
  • [44] mTOR inhibitors counteract tamoxifen-induced activation of breast cancer stem cells
    Karthik, Govindasamy-Muralidharan
    Ma, Ran
    Lovrot, John
    Kis, Lorand Levente
    Lindh, Claes
    Blomquist, Lennart
    Fredriksson, Irma
    Bergh, Jonas
    Hartman, Johan
    CANCER LETTERS, 2015, 367 (01) : 76 - 87
  • [45] AKT and/or mTOR inhibition as a potential target in trastuzumab resistant breast cancer cells with MUC-4 overexpression
    Perez-Fidalgo, J. A.
    Espin, E.
    Tormo, E.
    Pineda, B.
    Cejalvo, J. M.
    Sabbaghi, M. A.
    Alonso, E.
    Rovira, A.
    Rojo, F.
    Albanell, J.
    Bermejo, B.
    Burgues, O.
    Lluch, A.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S17 - S17
  • [46] Functional analysis of the effects of propofol on tamoxifen-resistant breast cancer cells: Insights into transcriptional regulation
    Yin, Runyang
    Gao, Jing
    Liu, Yang
    Guo, Chunyan
    ONCOLOGY LETTERS, 2025, 29 (04)
  • [47] Disruption of insulin receptor function inhibits proliferation in endocrine-resistant breast cancer cells
    J Y Chan
    K LaPara
    D Yee
    Oncogene, 2016, 35 : 4235 - 4243
  • [48] Disruption of insulin receptor function inhibits proliferation in endocrine-resistant breast cancer cells
    Chan, J. Y.
    LaPara, K.
    Yee, D.
    ONCOGENE, 2016, 35 (32) : 4235 - 4243
  • [49] Fatty acid synthase inhibition targets ERa in tamoxifen-resistant breast cancer
    Mcclellan, Bryan
    Gruslova, Aleksandra
    Jolly, Christopher
    deGraffenried, Linda
    Brenner, Andrew
    CANCER RESEARCH, 2021, 81 (04)
  • [50] Effective Tumor inhibition by the combination of GHRH Antagonist JMR 132 and Tamoxifen in hormone receptor breast cancer cells
    Buchholz, S.
    Seitz, S.
    Koester, F.
    Schally, A., V
    Ortmann, O.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2009, 69 (08) : 736 - 737
12345